Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use
CPT4 code
Name of the Procedure:
Zoster (Shingles) Vaccine (HZV), Recombinant, Subunit, Adjuvanted, for Intramuscular Use
Common Name: Shingrix
Summary
The Zoster vaccine, also known as Shingrix, is an injection given to prevent shingles, a painful rash caused by the reactivation of the chickenpox virus. The vaccine helps boost the immune system to protect against shingles and its complications.
Purpose
The Shingrix vaccine is designed to prevent shingles (herpes zoster) and its complications, such as postherpetic neuralgia (PHN). It helps reduce the likelihood of developing shingles and minimizes the severity and duration if it does occur.
Indications
- Adults aged 50 years and older.
- Individuals aged 18 years and older with increased risk due to immunosuppression or other medical conditions.
- Those who have had shingles previously to prevent recurrence.
Preparation
- No specific fasting or dietary restrictions required.
- Inform your healthcare provider of any allergic reactions to vaccines.
- Discuss your medical history, especially immune system disorders or treatments, with your healthcare provider.
- Usually, no diagnostic tests are required beforehand.
Procedure Description
- The patient will sit or lie down.
- The healthcare provider cleans the injection site, typically the upper arm.
- Using a sterile technique, the vaccine is administered intramuscularly with a syringe and needle.
- The procedure involves two doses, given 2 to 6 months apart.
Duration
The administration of each dose takes just a few minutes.
Setting
The vaccination is typically performed in outpatient settings such as a doctor's office, clinic, or pharmacy.
Personnel
- Administered by a healthcare provider, such as a nurse or medical assistant.
Risks and Complications
- Common: Soreness, redness, or swelling at the injection site, headaches, fatigue, muscle pain, fever.
- Rare: Severe allergic reactions, such as anaphylaxis.
- Management: Over-the-counter pain relievers can help alleviate symptoms; seek immediate medical attention for severe reactions.
Benefits
- High efficacy in preventing shingles and related complications.
- Long-lasting protection, significantly reducing the risk of shingles for up to several years post-vaccination.
- Early benefits typically realized within a few weeks after the second dose.
Recovery
- Mild side effects usually resolve within a few days.
- Follow any specific post-vaccination instructions given by your healthcare provider.
- Regular activities can typically be resumed immediately.
Alternatives
- Zostavax: An older live vaccine offering shingles protection but less effective compared to Shingrix.
- Pros: Single dose.
- Cons: Lower efficacy, potential contraindication in immunocompromised individuals.
- No vaccination: Risks include higher chances of developing shingles and potential complications.
Patient Experience
- During: A brief pinch or sting at the injection site.
- After: Possible mild discomfort or local reactions, which generally subside within a few days.
- Pain Management: Over-the-counter pain relief, cold compresses at the injection site, rest.